Archexin

Why Rexahn Pharmaceuticals (RNN) Is Up Today
TheStreet.com
Fri, 01/10/14 - 10:56 am
Rexahn
Archexin
Supinoxin
RX-3117
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
Seeking Alpha
Tue, 08/6/13 - 10:49 am
Rexahn
Merck
Novo Nordisk
Teva
Archexin
cancer
Rexahn says to continue RX-3117 development with Teva
The Fly on the Wall
Tue, 02/19/13 - 10:07 am
Rexahn
RX-3117
Teva
RX-5902
Archexin
Rexahn Pharmaceuticals: Update On Cancer Drugs
Seeking Alpha
Fri, 05/18/12 - 11:00 am
Teva Pharmaceuticals
Rexahn
Archexin
RX-3117
RX-5902
RX-8243
cancer
akt protein inhibitor